ICD-10-CM/PCS MS-DRG v42.0 Definitions Manual
![Previous Page [Alt-p]](bakpg.png){kind=small}
![Up a level [Alt-u]](uptop.png){kind=small}
![Next Page [Alt-n]](fwdpg.png){kind=small}
ICD-10-CM/PCS MS-DRG v42.0 Definitions Manual |
||||
| Skip to content | |
|
|
| MDC 23 Factors influencing health status and other contacts with health services |
| Other factors influencing health status |
| Page 1 of 4 |
| DRG |
|---|
| 951 |
DRG 951 OTHER FACTORS INFLUENCING HEALTH STATUS
PRINCIPAL DIAGNOSIS
| F17200 | Nicotine dependence, unspecified, uncomplicated |
| F17201 | Nicotine dependence, unspecified, in remission |
| F17210 | Nicotine dependence, cigarettes, uncomplicated |
| F17211 | Nicotine dependence, cigarettes, in remission |
| F17220 | Nicotine dependence, chewing tobacco, uncomplicated |
| F17221 | Nicotine dependence, chewing tobacco, in remission |
| F17290 | Nicotine dependence, other tobacco product, uncomplicated |
| F17291 | Nicotine dependence, other tobacco product, in remission |
| J95850 | Mechanical complication of respirator |
| P002 | Newborn affected by maternal infectious and parasitic diseases |
| P0082 | Newborn affected by (positive) maternal group B streptococcus (GBS) colonization |
| P0089 | Newborn affected by other maternal conditions |
| Q899 | Congenital malformation, unspecified |
| Q920 | Whole chromosome trisomy, nonmosaicism (meiotic nondisjunction) |
| Q921 | Whole chromosome trisomy, mosaicism (mitotic nondisjunction) |
| Q922 | Partial trisomy |
| Q925 | Duplications with other complex rearrangements |
| Q9261 | Marker chromosomes in normal individual |
| Q9262 | Marker chromosomes in abnormal individual |
| Q927 | Triploidy and polyploidy |
| Q928 | Other specified trisomies and partial trisomies of autosomes |
| Q929 | Trisomy and partial trisomy of autosomes, unspecified |
| Q930 | Whole chromosome monosomy, nonmosaicism (meiotic nondisjunction) |
| Q931 | Whole chromosome monosomy, mosaicism (mitotic nondisjunction) |
| Q932 | Chromosome replaced with ring, dicentric or isochromosome |
| Q950 | Balanced translocation and insertion in normal individual |
| Q951 | Chromosome inversion in normal individual |
| Q952 | Balanced autosomal rearrangement in abnormal individual |
| Q953 | Balanced sex/autosomal rearrangement in abnormal individual |
| Q955 | Individual with autosomal fragile site |
| Q958 | Other balanced rearrangements and structural markers |
| Q959 | Balanced rearrangement and structural marker, unspecified |
| Q999 | Chromosomal abnormality, unspecified |
| R29700 | NIHSS score 0 |
| R29701 | NIHSS score 1 |
| R29702 | NIHSS score 2 |
| R29703 | NIHSS score 3 |
| R29704 | NIHSS score 4 |
| R29705 | NIHSS score 5 |
| R29706 | NIHSS score 6 |
| R29707 | NIHSS score 7 |
| R29708 | NIHSS score 8 |
| R29709 | NIHSS score 9 |
| R29710 | NIHSS score 10 |
| R29711 | NIHSS score 11 |
| R29712 | NIHSS score 12 |
| R29713 | NIHSS score 13 |
| R29714 | NIHSS score 14 |
| R29715 | NIHSS score 15 |
| R29716 | NIHSS score 16 |
| R29717 | NIHSS score 17 |
| R29718 | NIHSS score 18 |
| R29719 | NIHSS score 19 |
| R29720 | NIHSS score 20 |
| R29721 | NIHSS score 21 |
| R29722 | NIHSS score 22 |
| R29723 | NIHSS score 23 |
| R29724 | NIHSS score 24 |
| R29725 | NIHSS score 25 |
| R29726 | NIHSS score 26 |
| R29727 | NIHSS score 27 |
| R29728 | NIHSS score 28 |
| R29729 | NIHSS score 29 |
| R29730 | NIHSS score 30 |
| R29731 | NIHSS score 31 |
| R29732 | NIHSS score 32 |
| R29733 | NIHSS score 33 |
| R29734 | NIHSS score 34 |
| R29735 | NIHSS score 35 |
| R29736 | NIHSS score 36 |
| R29737 | NIHSS score 37 |
| R29738 | NIHSS score 38 |
| R29739 | NIHSS score 39 |
| R29740 | NIHSS score 40 |
| R29741 | NIHSS score 41 |
| R29742 | NIHSS score 42 |
| R402130 | Coma scale, eyes open, to sound, unspecified time |
| R402131 | Coma scale, eyes open, to sound, in the field [EMT or ambulance] |
| R402132 | Coma scale, eyes open, to sound, at arrival to emergency department |
| R402133 | Coma scale, eyes open, to sound, at hospital admission |
| R402134 | Coma scale, eyes open, to sound, 24 hours or more after hospital admission |
| R402140 | Coma scale, eyes open, spontaneous, unspecified time |
| R402141 | Coma scale, eyes open, spontaneous, in the field [EMT or ambulance] |
| R402142 | Coma scale, eyes open, spontaneous, at arrival to emergency department |
| R402143 | Coma scale, eyes open, spontaneous, at hospital admission |
| R402144 | Coma scale, eyes open, spontaneous, 24 hours or more after hospital admission |
| R402230 | Coma scale, best verbal response, inappropriate words, unspecified time |
| R402231 | Coma scale, best verbal response, inappropriate words, in the field [EMT or ambulance] |
| R402232 | Coma scale, best verbal response, inappropriate words, at arrival to emergency department |
| R402233 | Coma scale, best verbal response, inappropriate words, at hospital admission |
| R402234 | Coma scale, best verbal response, inappropriate words, 24 hours or more after hospital admission |
| R402240 | Coma scale, best verbal response, confused conversation, unspecified time |
| R402241 | Coma scale, best verbal response, confused conversation, in the field [EMT or ambulance] |
| R402242 | Coma scale, best verbal response, confused conversation, at arrival to emergency department |
| R402243 | Coma scale, best verbal response, confused conversation, at hospital admission |
| R402244 | Coma scale, best verbal response, confused conversation, 24 hours or more after hospital admission |
| R402250 | Coma scale, best verbal response, oriented, unspecified time |
| R402251 | Coma scale, best verbal response, oriented, in the field [EMT or ambulance] |
| R402252 | Coma scale, best verbal response, oriented, at arrival to emergency department |
| R402253 | Coma scale, best verbal response, oriented, at hospital admission |
| R402254 | Coma scale, best verbal response, oriented, 24 hours or more after hospital admission |
| R402330 | Coma scale, best motor response, abnormal flexion, unspecified time |
| R402331 | Coma scale, best motor response, abnormal flexion, in the field [EMT or ambulance] |
| R402332 | Coma scale, best motor response, abnormal flexion, at arrival to emergency department |
| R402333 | Coma scale, best motor response, abnormal flexion, at hospital admission |
| R402334 | Coma scale, best motor response, abnormal flexion, 24 hours or more after hospital admission |
| R402350 | Coma scale, best motor response, localizes pain, unspecified time |
| R402351 | Coma scale, best motor response, localizes pain, in the field [EMT or ambulance] |
| R402352 | Coma scale, best motor response, localizes pain, at arrival to emergency department |
| R402353 | Coma scale, best motor response, localizes pain, at hospital admission |
| R402354 | Coma scale, best motor response, localizes pain, 24 hours or more after hospital admission |
| R402360 | Coma scale, best motor response, obeys commands, unspecified time |
| R402361 | Coma scale, best motor response, obeys commands, in the field [EMT or ambulance] |
| R402362 | Coma scale, best motor response, obeys commands, at arrival to emergency department |
| R402363 | Coma scale, best motor response, obeys commands, at hospital admission |
| R402364 | Coma scale, best motor response, obeys commands, 24 hours or more after hospital admission |
| R402410 | Glasgow coma scale score 13-15, unspecified time |
| R402411 | Glasgow coma scale score 13-15, in the field [EMT or ambulance] |
| R402412 | Glasgow coma scale score 13-15, at arrival to emergency department |
| R402413 | Glasgow coma scale score 13-15, at hospital admission |
| R402414 | Glasgow coma scale score 13-15, 24 hours or more after hospital admission |
| R402420 | Glasgow coma scale score 9-12, unspecified time |
| R402421 | Glasgow coma scale score 9-12, in the field [EMT or ambulance] |
| R402422 | Glasgow coma scale score 9-12, at arrival to emergency department |
| R402423 | Glasgow coma scale score 9-12, at hospital admission |
| R402424 | Glasgow coma scale score 9-12, 24 hours or more after hospital admission |
| R402430 | Glasgow coma scale score 3-8, unspecified time |
| R402431 | Glasgow coma scale score 3-8, in the field [EMT or ambulance] |
| R402432 | Glasgow coma scale score 3-8, at arrival to emergency department |
| R402433 | Glasgow coma scale score 3-8, at hospital admission |
| R402434 | Glasgow coma scale score 3-8, 24 hours or more after hospital admission |
| R402440 | Other coma, without documented Glasgow coma scale score, or with partial score reported, unspecified time |
| R402441 | Other coma, without documented Glasgow coma scale score, or with partial score reported, in the field [EMT or ambulance] |
| R402442 | Other coma, without documented Glasgow coma scale score, or with partial score reported, at arrival to emergency department |
| R402443 | Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission |
| R402444 | Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission |
| R4183 | Borderline intellectual functioning |
| R448 | Other symptoms and signs involving general sensations and perceptions |
| R449 | Unspecified symptoms and signs involving general sensations and perceptions |
| R45850 | Homicidal ideations |
| R460 | Very low level of personal hygiene |
| R461 | Bizarre personal appearance |
| R462 | Strange and inexplicable behavior |
| R463 | Overactivity |
| R464 | Slowness and poor responsiveness |
| R465 | Suspiciousness and marked evasiveness |
| R466 | Undue concern and preoccupation with stressful events |
| R467 | Verbosity and circumstantial detail obscuring reason for contact |
| R4681 | Obsessive-compulsive behavior |
| R4689 | Other symptoms and signs involving appearance and behavior |
| R6813 | Apparent life threatening event in infant (ALTE) |
| R6819 | Other nonspecific symptoms peculiar to infancy |
| R6882 | Decreased libido |
| R69 | Illness, unspecified |
| R99 | Ill-defined and unknown cause of mortality |
| T360X6A | Underdosing of penicillins, initial encounter |
| T361X6A | Underdosing of cephalosporins and other beta-lactam antibiotics, initial encounter |
| T362X6A | Underdosing of chloramphenicol group, initial encounter |
| T363X6A | Underdosing of macrolides, initial encounter |
| T364X6A | Underdosing of tetracyclines, initial encounter |
| T365X6A | Underdosing of aminoglycosides, initial encounter |
| T366X6A | Underdosing of rifampicins, initial encounter |
| T367X6A | Underdosing of antifungal antibiotics, systemically used, initial encounter |
| T368X6A | Underdosing of other systemic antibiotics, initial encounter |
| T3696XA | Underdosing of unspecified systemic antibiotic, initial encounter |
| T370X6A | Underdosing of sulfonamides, initial encounter |
| T371X6A | Underdosing of antimycobacterial drugs, initial encounter |
| T372X6A | Underdosing of antimalarials and drugs acting on other blood protozoa, initial encounter |
| T373X6A | Underdosing of other antiprotozoal drugs, initial encounter |
| T374X6A | Underdosing of anthelminthics, initial encounter |
| T375X6A | Underdosing of antiviral drugs, initial encounter |
| T378X6A | Underdosing of other specified systemic anti-infectives and antiparasitics, initial encounter |
| T3796XA | Underdosing of unspecified systemic anti-infectives and antiparasitics, initial encounter |
| T380X6A | Underdosing of glucocorticoids and synthetic analogues, initial encounter |
| T381X6A | Underdosing of thyroid hormones and substitutes, initial encounter |
| T382X6A | Underdosing of antithyroid drugs, initial encounter |
| T383X6A | Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter |
| T384X6A | Underdosing of oral contraceptives, initial encounter |
| T385X6A | Underdosing of other estrogens and progestogens, initial encounter |
| T386X6A | Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter |
| T387X6A | Underdosing of androgens and anabolic congeners, initial encounter |
| T38806A | Underdosing of unspecified hormones and synthetic substitutes, initial encounter |
| T38816A | Underdosing of anterior pituitary [adenohypophyseal] hormones, initial encounter |
| T38896A | Underdosing of other hormones and synthetic substitutes, initial encounter |
| T38906A | Underdosing of unspecified hormone antagonists, initial encounter |
| T38996A | Underdosing of other hormone antagonists, initial encounter |
| T39016A | Underdosing of aspirin, initial encounter |
| T39096A | Underdosing of salicylates, initial encounter |
| T391X6A | Underdosing of 4-Aminophenol derivatives, initial encounter |
| T392X6A | Underdosing of pyrazolone derivatives, initial encounter |
| T39316A | Underdosing of propionic acid derivatives, initial encounter |
| T39396A | Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter |
| T394X6A | Underdosing of antirheumatics, not elsewhere classified, initial encounter |
| T398X6A | Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter |
| T3996XA | Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter |
| T400X6A | Underdosing of opium, initial encounter |
| T402X6A | Underdosing of other opioids, initial encounter |
| T403X6A | Underdosing of methadone, initial encounter |
| T40416A | Underdosing of fentanyl or fentanyl analogs, initial encounter |
| T40426A | Underdosing of tramadol, initial encounter |
| T40496A | Underdosing of other synthetic narcotics, initial encounter |
| T405X6A | Underdosing of cocaine, initial encounter |
| T40606A | Underdosing of unspecified narcotics, initial encounter |
| T40696A | Underdosing of other narcotics, initial encounter |
| T40716A | Underdosing of cannabis, initial encounter |
| T40726A | Underdosing of synthetic cannabinoids, initial encounter |
| T40906A | Underdosing of unspecified psychodysleptics [hallucinogens], initial encounter |
| T40996A | Underdosing of other psychodysleptics [hallucinogens], initial encounter |
| T410X6A | Underdosing of inhaled anesthetics, initial encounter |
| T411X6A | Underdosing of intravenous anesthetics, initial encounter |
| T41206A | Underdosing of unspecified general anesthetics, initial encounter |
| T41296A | Underdosing of other general anesthetics, initial encounter |
| T413X6A | Underdosing of local anesthetics, initial encounter |
| T4146XA | Underdosing of unspecified anesthetics, initial encounter |
| T415X6A | Underdosing of therapeutic gases, initial encounter |
| T420X6A | Underdosing of hydantoin derivatives, initial encounter |
| T421X6A | Underdosing of iminostilbenes, initial encounter |
| T422X6A | Underdosing of succinimides and oxazolidinediones, initial encounter |
| T423X6A | Underdosing of barbiturates, initial encounter |
| T424X6A | Underdosing of benzodiazepines, initial encounter |
| T425X6A | Underdosing of mixed antiepileptics, initial encounter |
| T426X6A | Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter |
| T4276XA | Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter |
| T428X6A | Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter |
| T43016A | Underdosing of tricyclic antidepressants, initial encounter |
| T43026A | Underdosing of tetracyclic antidepressants, initial encounter |
| T431X6A | Underdosing of monoamine-oxidase-inhibitor antidepressants, initial encounter |
| T43206A | Underdosing of unspecified antidepressants, initial encounter |
| T43216A | Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter |
| T43226A | Underdosing of selective serotonin reuptake inhibitors, initial encounter |
| T43296A | Underdosing of other antidepressants, initial encounter |
| T433X6A | Underdosing of phenothiazine antipsychotics and neuroleptics, initial encounter |
| T434X6A | Underdosing of butyrophenone and thiothixene neuroleptics, initial encounter |
| T43506A | Underdosing of unspecified antipsychotics and neuroleptics, initial encounter |
| T43596A | Underdosing of other antipsychotics and neuroleptics, initial encounter |
| T43606A | Underdosing of unspecified psychostimulants, initial encounter |
| T43616A | Underdosing of caffeine, initial encounter |
| T43626A | Underdosing of amphetamines, initial encounter |
| T43636A | Underdosing of methylphenidate, initial encounter |
| T43656A | Underdosing of methamphetamines, initial encounter |
| T43696A | Underdosing of other psychostimulants, initial encounter |
| T438X6A | Underdosing of other psychotropic drugs, initial encounter |
| T4396XA | Underdosing of unspecified psychotropic drug, initial encounter |
| T440X6A | Underdosing of anticholinesterase agents, initial encounter |
| T441X6A | Underdosing of other parasympathomimetics [cholinergics], initial encounter |
| T442X6A | Underdosing of ganglionic blocking drugs, initial encounter |
| T443X6A | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter |
| T444X6A | Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter |
| T445X6A | Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter |
| T446X6A | Underdosing of alpha-adrenoreceptor antagonists, initial encounter |
| T447X6A | Underdosing of beta-adrenoreceptor antagonists, initial encounter |
| T448X6A | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounter |
| T44906A | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter |
| T44996A | Underdosing of other drug primarily affecting the autonomic nervous system, initial encounter |
| T450X6A | Underdosing of antiallergic and antiemetic drugs, initial encounter |
| T451X6A | Underdosing of antineoplastic and immunosuppressive drugs, initial encounter |
| T452X6A | Underdosing of vitamins, initial encounter |
| T453X6A | Underdosing of enzymes, initial encounter |
| T454X6A | Underdosing of iron and its compounds, initial encounter |
| T45516A | Underdosing of anticoagulants, initial encounter |
| T45526A | Underdosing of antithrombotic drugs, initial encounter |
| T45606A | Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter |
| T45616A | Underdosing of thrombolytic drugs, initial encounter |
| T45626A | Underdosing of hemostatic drugs, initial encounter |
| T45696A | Underdosing of other fibrinolysis-affecting drugs, initial encounter |
| T457X6A | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter |
| T458X6A | Underdosing of other primarily systemic and hematological agents, initial encounter |
| T4596XA | Underdosing of unspecified primarily systemic and hematological agent, initial encounter |
| T45AX6A | Underdosing of immune checkpoint inhibitors and immunostimulant drugs, initial encounter |
| T460X6A | Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter |
| T461X6A | Underdosing of calcium-channel blockers, initial encounter |
| T462X6A | Underdosing of other antidysrhythmic drugs, initial encounter |
| T463X6A | Underdosing of coronary vasodilators, initial encounter |
| T464X6A | Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter |
| T465X6A | Underdosing of other antihypertensive drugs, initial encounter |
| T466X6A | Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter |
| T467X6A | Underdosing of peripheral vasodilators, initial encounter |
| T468X6A | Underdosing of antivaricose drugs, including sclerosing agents, initial encounter |
| T46906A | Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter |
| T46996A | Underdosing of other agents primarily affecting the cardiovascular system, initial encounter |
| T470X6A | Underdosing of histamine H2-receptor blockers, initial encounter |
| T471X6A | Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter |
| T472X6A | Underdosing of stimulant laxatives, initial encounter |
| T473X6A | Underdosing of saline and osmotic laxatives, initial encounter |
| T474X6A | Underdosing of other laxatives, initial encounter |
| T475X6A | Underdosing of digestants, initial encounter |
| T476X6A | Underdosing of antidiarrheal drugs, initial encounter |
| T477X6A | Underdosing of emetics, initial encounter |
| T478X6A | Underdosing of other agents primarily affecting gastrointestinal system, initial encounter |
| T4796XA | Underdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounter |
| T480X6A | Underdosing of oxytocic drugs, initial encounter |
| T481X6A | Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter |
| T48206A | Underdosing of unspecified drugs acting on muscles, initial encounter |
| T48296A | Underdosing of other drugs acting on muscles, initial encounter |
| T483X6A | Underdosing of antitussives, initial encounter |
| T484X6A | Underdosing of expectorants, initial encounter |
| T485X6A | Underdosing of other anti-common-cold drugs, initial encounter |
| T486X6A | Underdosing of antiasthmatics, initial encounter |
| T48906A | Underdosing of unspecified agents primarily acting on the respiratory system, initial encounter |
| T48996A | Underdosing of other agents primarily acting on the respiratory system, initial encounter |
| T490X6A | Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter |
| T491X6A | Underdosing of antipruritics, initial encounter |
| T492X6A | Underdosing of local astringents and local detergents, initial encounter |
| T493X6A | Underdosing of emollients, demulcents and protectants, initial encounter |
| T494X6A | Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter |
| T495X6A | Underdosing of ophthalmological drugs and preparations, initial encounter |
| T496X6A | Underdosing of otorhinolaryngological drugs and preparations, initial encounter |
| T497X6A | Underdosing of dental drugs, topically applied, initial encounter |
| T498X6A | Underdosing of other topical agents, initial encounter |
| T4996XA | Underdosing of unspecified topical agent, initial encounter |
| T500X6A | Underdosing of mineralocorticoids and their antagonists, initial encounter |
| T501X6A | Underdosing of loop [high-ceiling] diuretics, initial encounter |
| T502X6A | Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter |
| T503X6A | Underdosing of electrolytic, caloric and water-balance agents, initial encounter |
| T504X6A | Underdosing of drugs affecting uric acid metabolism, initial encounter |
| T505X6A | Underdosing of appetite depressants, initial encounter |
| T506X6A | Underdosing of antidotes and chelating agents, initial encounter |
| T507X6A | Underdosing of analeptics and opioid receptor antagonists, initial encounter |
| T508X6A | Underdosing of diagnostic agents, initial encounter |
| T50906A | Underdosing of unspecified drugs, medicaments and biological substances, initial encounter |
| T50916A | Underdosing of multiple unspecified drugs, medicaments and biological substances, initial encounter |
| T50996A | Underdosing of other drugs, medicaments and biological substances, initial encounter |
| T50A16A | Underdosing of pertussis vaccine, including combinations with a pertussis component, initial encounter |
| T50A26A | Underdosing of mixed bacterial vaccines without a pertussis component, initial encounter |
| T50A96A | Underdosing of other bacterial vaccines, initial encounter |
| T50B16A | Underdosing of smallpox vaccines, initial encounter |
| T50B96A | Underdosing of other viral vaccines, initial encounter |
| T50Z16A | Underdosing of immunoglobulin, initial encounter |
| T50Z96A | Underdosing of other vaccines and biological substances, initial encounter |
| U099 | Post COVID-19 condition, unspecified |
| Z0000 | Encounter for general adult medical examination without abnormal findings |
| Z0001 | Encounter for general adult medical examination with abnormal findings |
| Z00110 | Health examination for newborn under 8 days old |
| Z00111 | Health examination for newborn 8 to 28 days old |
| Z00121 | Encounter for routine child health examination with abnormal findings |
| Z00129 | Encounter for routine child health examination without abnormal findings |
| Z002 | Encounter for examination for period of rapid growth in childhood |
| Z003 | Encounter for examination for adolescent development state |
| Z005 | Encounter for examination of potential donor of organ and tissue |
| Z006 | Encounter for examination for normal comparison and control in clinical research program |
| Z0070 | Encounter for examination for period of delayed growth in childhood without abnormal findings |
| Z0071 | Encounter for examination for period of delayed growth in childhood with abnormal findings |
| Z008 | Encounter for other general examination |
| Z0100 | Encounter for examination of eyes and vision without abnormal findings |
| Z0101 | Encounter for examination of eyes and vision with abnormal findings |
| Z01020 | Encounter for examination of eyes and vision following failed vision screening without abnormal findings |
| Z01021 | Encounter for examination of eyes and vision following failed vision screening with abnormal findings |
| Z0110 | Encounter for examination of ears and hearing without abnormal findings |
| Z01110 | Encounter for hearing examination following failed hearing screening |
| Z01118 | Encounter for examination of ears and hearing with other abnormal findings |
| Z0112 | Encounter for hearing conservation and treatment |
| Z0120 | Encounter for dental examination and cleaning without abnormal findings |
| Z0121 | Encounter for dental examination and cleaning with abnormal findings |
| Z0130 | Encounter for examination of blood pressure without abnormal findings |
| Z0131 | Encounter for examination of blood pressure with abnormal findings |
| Z01411 | Encounter for gynecological examination (general) (routine) with abnormal findings |
| Z01419 | Encounter for gynecological examination (general) (routine) without abnormal findings |
| Z0142 | Encounter for cervical smear to confirm findings of recent normal smear following initial abnormal smear |
| Z01810 | Encounter for preprocedural cardiovascular examination |
| Z01811 | Encounter for preprocedural respiratory examination |
| Z01812 | Encounter for preprocedural laboratory examination |
| Z01818 | Encounter for other preprocedural examination |
| Z0182 | Encounter for allergy testing |
| Z0183 | Encounter for blood typing |
| Z0184 | Encounter for antibody response examination |
| Z0189 | Encounter for other specified special examinations |
| Z020 | Encounter for examination for admission to educational institution |
| Z021 | Encounter for pre-employment examination |
| Z022 | Encounter for examination for admission to residential institution |
| Z023 | Encounter for examination for recruitment to armed forces |
| Z024 | Encounter for examination for driving license |
| Z025 | Encounter for examination for participation in sport |
| Z026 | Encounter for examination for insurance purposes |
| Z0271 | Encounter for disability determination |
| Z0279 | Encounter for issue of other medical certificate |
| Z0281 | Encounter for paternity testing |
| Z0282 | Encounter for adoption services |
| Z0283 | Encounter for blood-alcohol and blood-drug test |
| Z0284 | Encounter for child welfare exam |
| Z0289 | Encounter for other administrative examinations |
| Z029 | Encounter for administrative examinations, unspecified |
| Z036 | Encounter for observation for suspected toxic effect from ingested substance ruled out |
| Z0371 | Encounter for suspected problem with amniotic cavity and membrane ruled out |
| Z0372 | Encounter for suspected placental problem ruled out |
| Z0373 | Encounter for suspected fetal anomaly ruled out |
| Z0374 | Encounter for suspected problem with fetal growth ruled out |
| Z0375 | Encounter for suspected cervical shortening ruled out |
| Z0379 | Encounter for other suspected maternal and fetal conditions ruled out |
| Z03810 | Encounter for observation for suspected exposure to anthrax ruled out |
| Z03818 | Encounter for observation for suspected exposure to other biological agents ruled out |
| Z03821 | Encounter for observation for suspected ingested foreign body ruled out |
| Z03822 | Encounter for observation for suspected aspirated (inhaled) foreign body ruled out |
| Z03823 | Encounter for observation for suspected inserted (injected) foreign body ruled out |
| Z0383 | Encounter for observation for suspected conditions related to home physiologic monitoring device ruled out |
| Z0389 | Encounter for observation for other suspected diseases and conditions ruled out |
| Z0441 | Encounter for examination and observation following alleged adult rape |
|
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 29 Mar 2024 17:03:46 CMS, code-revision=361, description-revision=1397 |